Traditional friendship between China and North Korea represents "valuable wealth" for their people, China said. » Read More
By: Jim Cramer
Jim Cramer examined the recent spate of Chinese companies coming public on U.S. exchanges and explained why they're not worth the investment. » Read More
By: Elizabeth Gurdus
Jim Cramer examined the recent spate of Chinese companies coming public on U.S. exchanges and explained why they're not worth buying. » Read More
Natalie Wu of CICC says Tencent can maintain its growth momentum after "very, very strong" third quarter earnings.
Kevin Lai, chief economist ex-Japan at Daiwa Capital Markets, says China's central bank has to balance liquidity and the yuan as it sets rates policy.
China has done an excellent job handling its economy, which is a "gift that keeps giving," says James Gorman, chairman & CEO of Morgan Stanley.
Andy Zhang, chairman and chief executive officer at Yixin Group, says online auto financing can "open an entry point" to offer customers related services.
Bob McCooey, senior vice president at Nasdaq, says there is a broad range of companies from China seeking IPOs on the exchange.
Despite debt concerns, China is "a gift that keeps giving," said Morgan Stanley Chairman and CEO James Gorman.
China is building the world's fastest wind tunnel to simulate hypersonic flight at speeds of up to 12 kilometers per second.
Ronald Wan of Partners Capital International says Tencent's communications platform is ripe for overseas expansion.
Private equity investment in China has shifted from the industrial space to the consumer sector, says Weijian Shan, PAG chairman and CEO.
Some analysts are watching the rise in China's 10-year sovereign bond yield as an indication that growth may slow and spill over to global markets.
A White House official said that the president's statement will center around the five-country tour of Asia, NBC News reported.
CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets.
Christian Hogg, Hutchison China MediTech executive director and CEO, discusses the growth of Chinese biotech companies and Chi-Med's drug development.
President Donald Trump sees India at the heart of his Asia policy, which is centered on a free and open Indo-Pacific
Rusal CFO Alexandra Bouriko speaks about her company's third-quarter earnings report and its environment initiatives.
Shanghai Pharmaceuticals has agreed to buy Cardinal Health's China drug distribution business for $557 million.
Victor Shih, policy professor at the University of California at San Diego, speaks about the leadership of the Chinese Communist Party.
Morgan Stanley is bullish on business in China as IPO activity picks up.
Douglas Feagin, SVP and head of global business at Ant Financial, addressed concerns about the company's asset-backed securities.
In order for financial technology to grow, some countries are giving firms freedom to experiment, lifting the burdens of regulation.